Highlights From Community Oncology Global Congress 2026, Day 1
VIRO 2026 – Global Voices in Renal Oncology
Phase 2 NEST Trial: Neoadjuvant BOT/BAL in Localized Colon Cancer
SKYSCRAPER-07: Atezolizumab ± Tiragolumab After dCRT in Unresectable ESCC
Michelle Mitchell: HPV Self-Testing Marks a Major Step Toward Eliminating Cervical Cancer
Manish Shah: Phase 2 NEST Trial Shows Promising Neoadjuvant BOT/BAL Results in Colon Cancer
Bristol Myers Squibb Invests $173 Million to Expand U.S. Radiopharmaceutical Manufacturing
When EGFR-Mutant NSCLC Becomes SCLC: Can Immunotherapy Become Relevant Again?
